In view of the success of targeting protein kinases in cancer chemotherapy, illustrated by the approval of several kinase inhibitors as anti-cancer drugs over the recent years [9], the Plasmodium kinome has been highlighted as a potential target for antimalarials with novel modes of action [10,11]. Here, WEE1 is linked to cancer.